Picture of Takeda Pharmaceutical Co logo

TAK Takeda Pharmaceutical Co News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD





 




RNS Number : 1620Y
Societe Generale SA
17 August 2018
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.

 

 

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Takeda Pharmaceutical CO LTD

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:


(e) Date position held/dealing undertaken:

     For an opening position disclosure, state the latest practicable date prior to the disclosure

16/08/2018

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"

YES: Shire PLC

 

 

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions


Number

%

Number

%

(1) Relevant securities owned and/or controlled:

1,609,962

0.21

6,009,541

0.77

(2) Cash-settled derivatives:

 

4,747,552

0.61

2,026

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

121,500

0.02

0

0.00

 

     TOTAL:

6,479,014

0.83

6,011,567

0.77

           

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)        Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:


Details, including nature of the rights concerned and relevant percentages:


 

 

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

JPY

Ordinary

Purchase

100

4558

Ordinary

Purchase

100

4558

Ordinary

Purchase

600

4551

Ordinary

Purchase

400

4608

Ordinary

Purchase

100

4608

Ordinary

Purchase

200

4608

Ordinary

Purchase

200

4615

Ordinary

Purchase

100

4551

Ordinary

Purchase

200

4551

Ordinary

Purchase

600

4551

Ordinary

Purchase

300

4572

Ordinary

Purchase

1,600

4613

Ordinary

Purchase

2,500

4613

Ordinary

Purchase

100

4555

Ordinary

Purchase

200

4551.5

Ordinary

Purchase

300

4559.5

Ordinary

Purchase

100

4550

Ordinary

Purchase

200

4536

Ordinary

Purchase

200

4538

Ordinary

Purchase

100

4602

Ordinary

Purchase

300

4542

Ordinary

Purchase

200

4537.5

Ordinary

Purchase

500

4539

Ordinary

Purchase

300

4540

Ordinary

Purchase

200

4542

Ordinary

Purchase

300

4541

Ordinary

Purchase

100

4600

Ordinary

Purchase

100

4600

Ordinary

Purchase

100

4559

Ordinary

Purchase

100

4604

Ordinary

Purchase

200

4538

Ordinary

Purchase

500

4610

Ordinary

Purchase

100

4557

Ordinary

Purchase

200

4540

Ordinary

Purchase

300

4606

Ordinary

Purchase

400

4537

Ordinary

Purchase

600

4608

Ordinary

Purchase

700

4538

Ordinary

Purchase

500

4538

Ordinary

Purchase

800

4558

Ordinary

Purchase

600

4539

Ordinary

Purchase

500

4533

Ordinary

Purchase

100

4532

Ordinary

Purchase

1,000

4550

Ordinary

Purchase

700

4549

Ordinary

Purchase

300

4555

Ordinary

Purchase

500

4556

Ordinary

Purchase

1,000

4585

Ordinary

Purchase

600

4585

Ordinary

Purchase

500

4611

Ordinary

Purchase

100

4559

Ordinary

Purchase

1,000

4603

Ordinary

Purchase

1,000

4541

Ordinary

Purchase

200

4541

Ordinary

Purchase

1,000

4601

Ordinary

Purchase

100

4562

Ordinary

Purchase

100

4536

Ordinary

Purchase

100

4544

Ordinary

Purchase

200

4608

Ordinary

Purchase

200

4548

Ordinary

Purchase

400

4613

Ordinary

Purchase

300

4614

Ordinary

Purchase

100

4548

Ordinary

Purchase

1,000

4549

Ordinary

Purchase

500

4621

Ordinary

Purchase

1,000

4614

Ordinary

Purchase

1,000

4543

Ordinary

Purchase

400

4542

Ordinary

Purchase

1,000

4543

Ordinary

Purchase

800

4594

Ordinary

Purchase

1,300

4583

Ordinary

Purchase

700

4550

Ordinary

Purchase

500

4621

Ordinary

Purchase

100

4557

Ordinary

Purchase

800

4606

Ordinary

Purchase

200

4617

Ordinary

Purchase

1,000

4621

Ordinary

Purchase

1,000

4614

Ordinary

Purchase

500

4603

Ordinary

Purchase

100

4600

Ordinary

Purchase

600

4618

Ordinary

Purchase

100

4546

Ordinary

Purchase

400

4546

Ordinary

Purchase

300

4602

Ordinary

Purchase

1,000

4618

Ordinary

Purchase

700

4610

Ordinary

Purchase

1,000

4545

Ordinary

Purchase

300

4542

Ordinary

Purchase

700

4542

Ordinary

Purchase

300

4550

Ordinary

Purchase

700

4555

Ordinary

Purchase

1,000

4551

Ordinary

Purchase

1,000

4555

Ordinary

Purchase

700

4540

Ordinary

Purchase

500

4608

Ordinary

Purchase

200

4605

Ordinary

Purchase

700

4611

Ordinary

Purchase

600

4603

Ordinary

Purchase

500

4603

Ordinary

Purchase

100

4539

Ordinary

Purchase

100

4539

Ordinary

Purchase

100

4537

Ordinary

Purchase

100

4542

Ordinary

Purchase

200

4603

Ordinary

Purchase

500

4557

Ordinary

Purchase

200

4538

Ordinary

Purchase

900

4604

Ordinary

Purchase

800

4539

Ordinary

Purchase

200

4539

Ordinary

Purchase

300

4607

Ordinary

Purchase

700

4616

Ordinary

Purchase

400

4541

Ordinary

Purchase

100

4616

Ordinary

Purchase

1,000

4560

Ordinary

Purchase

100

4608

Ordinary

Purchase

1,000

4617

Ordinary

Purchase

1,000

4542

Ordinary

Purchase

600

4542

Ordinary

Purchase

100

4534

Ordinary

Purchase

1,000

4608

Ordinary

Purchase

600

4608

Ordinary

Purchase

300

4572

Ordinary

Purchase

700

4620

Ordinary

Purchase

900

4604

Ordinary

Purchase

900

4566

Ordinary

Purchase

100

4546

Ordinary

Purchase

1,000

4575

Ordinary

Purchase

100

4610

Ordinary

Purchase

100

4550.9

Ordinary

Purchase

300

4549

Ordinary

Purchase

1,600

4615

Ordinary

Purchase

700

4612

Ordinary

Purchase

100

4617

Ordinary

Purchase

1,000

4615

Ordinary

Purchase

300

4617

Ordinary

Purchase

1,500

4618

Ordinary

Purchase

100

4603

Ordinary

Purchase

12,100

4613

Ordinary

Purchase

12,900

4613

Ordinary

Purchase

25,800

4540

Ordinary

Purchase

239

4540

Ordinary

Purchase

80

4490

Ordinary

Sale

200

4581

Ordinary

Sale

200

4582

Ordinary

Sale

300

4582

Ordinary

Sale

200

4613

Ordinary

Sale

200

4607

Ordinary

Sale

300

4605

Ordinary

Sale

300

4606

Ordinary

Sale

300

4566

Ordinary

Sale

600

4556

Ordinary

Sale

500

4538

Ordinary

Sale

100

4533

Ordinary

Sale

300

4536.5

Ordinary

Sale

2,900

4613

Ordinary

Sale

100

4616.5

Ordinary

Sale

700

4617

Ordinary

Sale

700

4543

Ordinary

Sale

700

4551

Ordinary

Sale

1,500

4550

Ordinary

Sale

200

4618

Ordinary

Sale

200

4585

Ordinary

Sale

100

4618

Ordinary

Sale

200

4609

Ordinary

Sale

500

4584

Ordinary

Sale

100

4541

Ordinary

Sale

1,200

4543

Ordinary

Sale

100

4544

Ordinary

Sale

900

4541

Ordinary

Sale

700

4555

Ordinary

Sale

200

4544

Ordinary

Sale

900

4541

Ordinary

Sale

300

4540

Ordinary

Sale

700

4612

Ordinary

Sale

100

4542

Ordinary

Sale

1,300

4542

Ordinary

Sale

500

4546

Ordinary

Sale

200

4545

Ordinary

Sale

500

4544

Ordinary

Sale

300

4584

Ordinary

Sale

700

4543

Ordinary

Sale

500

4579

Ordinary

Sale

500

4603

Ordinary

Sale

300

4611

Ordinary

Sale

200

4581

Ordinary

Sale

1,300

4580

Ordinary

Sale

100

4581

Ordinary

Sale

800

4558

Ordinary

Sale

200

4579

Ordinary

Sale

1,200

4536

Ordinary

Sale

2,400

4564

Ordinary

Sale

1,500

4602

Ordinary

Sale

100

4603

Ordinary

Sale

200

4538

Ordinary

Sale

700

4615

Ordinary

Sale

1,200

4539

Ordinary

Sale

200

4616

Ordinary

Sale

200

4561

Ordinary

Sale

300

4616

Ordinary

Sale

300

4562

Ordinary

Sale

200

4563

Ordinary

Sale

1,200

4560

Ordinary

Sale

1,300

4539

Ordinary

Sale

700

4609

Ordinary

Sale

400

4615

Ordinary

Sale

100

4548

Ordinary

Sale

200

4550

Ordinary

Sale

300

4550

Ordinary

Sale

2,100

4618

Ordinary

Sale

100

4614

Ordinary

Sale

300

4616

Ordinary

Sale

100

4565

Ordinary

Sale

200

4608

Ordinary

Sale

300

4541

Ordinary

Sale

1,300

4620

Ordinary

Sale

400

4603

Ordinary

Sale

1,200

4542

Ordinary

Sale

100

4613

Ordinary

Sale

1,200

4541

Ordinary

Sale

1,100

4610

Ordinary

Sale

700

4563

Ordinary

Sale

400

4551

Ordinary

Sale

600

4601

Ordinary

Sale

300

4599

Ordinary

Sale

700

4560

Ordinary

Sale

200

4561

Ordinary

Sale

400

4564

Ordinary

Sale

100

4561

Ordinary

Sale

100

4565

Ordinary

Sale

400

4610

Ordinary

Sale

600

4543

Ordinary

Sale

1,600

4531

Ordinary

Sale

500

4531

Ordinary

Sale

400

4539

Ordinary

Sale

200

4601

Ordinary

Sale

1,000

4610

Ordinary

Sale

500

4602

Ordinary

Sale

100

4618

Ordinary

Sale

300

4616

Ordinary

Sale

1,000

4621

Ordinary

Sale

1,200

4551

Ordinary

Sale

400

4613

Ordinary

Sale

100

4549

Ordinary

Sale

100

4550

Ordinary

Sale

1,200

4549

Ordinary

Sale

600

4536

Ordinary

Sale

200

4539

Ordinary

Sale

1,600

4554

Ordinary

Sale

200

4599

Ordinary

Sale

500

4618

Ordinary

Sale

600

4549

Ordinary

Sale

1,200

4609

Ordinary

Sale

600

4546

Ordinary

Sale

500

4601

Ordinary

Sale

1,200

4540

Ordinary

Sale

100

4546

Ordinary

Sale

900

4612

Ordinary

Sale

200

4572

Ordinary

Sale

1,900

4608

Ordinary

Sale

800

4544

Ordinary

Sale

200

4605

Ordinary

Sale

1,200

4556

Ordinary

Sale

100

4571

Ordinary

Sale

300

4570

Ordinary

Sale

2,000

4608

Ordinary

Sale

100

4609

Ordinary

Sale

1,500

4607

Ordinary

Sale

800

4607

Ordinary

Sale

200

4604

Ordinary

Sale

200

4608

Ordinary

Sale

100

4551

Ordinary

Sale

300

4608

Ordinary

Sale

200

4549

Ordinary

Sale

1,200

4540

Ordinary

Sale

400

4562

Ordinary

Sale

1,200

4616

Ordinary

Sale

100

4563

Ordinary

Sale

1,300

4540

Ordinary

Sale

1,200

4616

Ordinary

Sale

1,300

4617

Ordinary

Sale

1,200

4540

Ordinary

Sale

500

4607

Ordinary

Sale

400

4539

Ordinary

Sale

1,200

4559

Ordinary

Sale

200

4538

Ordinary

Sale

900

4537

Ordinary

Sale

100

4537

Ordinary

Sale

600

4545

Ordinary

Sale

100

4544

Ordinary

Sale

700

4566

Ordinary

Sale

600

4617

Ordinary

Sale

900

4550

Ordinary

Sale

1,600

4611

Ordinary

Sale

300

4613

Ordinary

Sale

500

4540

Ordinary

Sale

15,000

4613

Ordinary

Sale

16,780

4588.3433

Ordinary

Sale

164

4587


Total Purchases

119,419



Total Sales

124,844


 

 

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit JPY

Ordinary

CFD

Increasing a long position

16,780

4588.3433

 

 (c)       Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit JPY









 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit JPY





 

 

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) JPY


 

 



4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c)        Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

Date of disclosure:

17/08/2018

Contact name:

Olivier Vero

Telephone number:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

 

 



SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1.         KEY INFORMATION

 

Full name of person making disclosure:

SOCIETE GENERALE SA

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Takeda Pharmaceutical CO LTD

 

2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

 

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

Expiry date

JPY

e.g. American, European etc.

Ordinary

OTC put-option

Sale

15,700

4707

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,000

5075.10

European options

14/12/2018

Ordinary

OTC put-option

Sale

29,600

5073.65

European options

14/12/2018

Ordinary

OTC put-option

Sale

15,500

4491.40

European options

14/12/2018

Ordinary

OTC put-option

Sale

30,700

4533.90

European options

14/12/2018

 

 

 

3.         AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETGGUUARUPRUBM

Recent news on Takeda Pharmaceutical Co

See all news